Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
Anna Kron(University Hospital Cologne), Christina Alidousty(University Hospital Cologne), Matthias Scheffler(University Hospital Cologne), Sabine Merkelbach‐Bruse(University Hospital Cologne), Danila Seidel(University of Cologne), Richard Riedel(University Hospital Cologne), Michaela A. Ihle(University Hospital Cologne), Sebastian Michels(University Hospital Cologne), Lucia Nogová(University Hospital Cologne), Jana Fassunke(University Hospital Cologne), Carina Heydt(University Hospital Cologne), Florian Kron(Integrated Oncology (United States)), F. Ueckeroth(University Hospital Cologne), Monika Serke(Lungenklinik Hemer), Stefan Krüger(Nightingale Hospital), Christian Grohé(Paul Gerhardt Diakonie), Dirk Koschel(St. Hedwig-Krankenhaus), J Benedikter(München Klinik Bogenhausen), B. Kaminsky(Krankenhaus Bethanien), Bernhard Schaaf(Klinikum Dortmund), Jan Braess(Krankenhaus Barmherzige Brüder), Martin Sebastian(Goethe University Frankfurt), Kato Kambartel(Krankenhaus Bethanien), Roman K. Thomas(University Hospital Cologne), Thomas Zander(Integrated Oncology (United States)), Anne M. Schultheis(University Hospital Cologne), Reinhard Büttner(University Hospital Cologne), Jennifer Moriatis Wolf(University Hospital Cologne)
Cited by 209Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis